Evaluating Risk Factors and Biomarkers for Adaptation and Resilience to Spaceflight
1 other identifier
interventional
32
1 country
1
Brief Summary
This study assesses differences in biological and behavioral domains that relate to individual adaptation and resiliency to an isolated, confined and controlled environment, and evaluates the effect of confinement, work, monotony, and social and physical isolation on stress resiliency and well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedStudy Start
First participant enrolled
February 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedApril 6, 2025
April 1, 2025
5.8 years
December 14, 2018
April 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Resilience
Change in Resilience
Days 1 and 8
Secondary Outcomes (7)
Stress
Days 1-8
Biomarker-Response to Stress
Days 2, 4, 6, 8
Brain Structure
Days 1 and 8
Brain Function
Days 1 and 8
Cognitive Performance
Days 2-8
- +2 more secondary outcomes
Study Arms (1)
8-Days in an Isolation, Confinement Unit
EXPERIMENTALSubjects will spend 7-night/8-day in an isolated and confined unit with up to 3 other subjects.
Interventions
Subjects will spend 8 days/7 nights continuously in an isolated and confined unit with up to 3 other subjects. Subjects will participate in daily, timed activities such as space-relevant computer simulations, team tasks, and cognitive performance testing. Subjects will also experience altered environmental conditions (such as changes in lighting, sound and ambient temperature) while in the isolation unit. Subjects will receive orders from "mission control" who will monitor activity in the isolation unit and direct subjects throughout the 8-day study.
Eligibility Criteria
You may qualify if:
- Age between 30 and 55 years
- A master's degree (or its equivalency in work experience) in Science, Technology, Engineering and Math (STEM) or military service
- Free of psychological/psychiatric conditions that preclude participation
- BMI \< 35
- Ability to read/write English
You may not qualify if:
- History of neurological, psychiatric, or other medical condition that excludes participation
- Current mania or psychosis
- Current depression
- Current poor resiliency
- Alcohol or drug abuse in the past year based upon history and urine toxicology screen.
- Current smoker/tobacco user.
- Acute, chronic, or debilitating medical conditions, major Axis I psychiatric illness, epilepsy, or thyroid disease based
- Cardiovascular, neurological, gastrointestinal, or musculoskeletal problems that exclude participation
- For MRI testing any of the following conditions may exclude subjects from participation in the present experiment: Tinnitus; sensorineural hearing loss \> 30 decibels; pace maker or internal defibrillator; metallic implants (e.g. orthopedic plates after bone fractures, joint replacements, surgical staples or clips, artificial heart valves, stents, cava filters); metallic splinters (e.g. after an accident or due to war injury); non-removable dental brace; tattoo (some tattoo inks contain metallic particles); permanent make-up; intrauterine contraceptive device; cochlear implant (implanted hearing device); medication pump; acupuncture needle; other foreign bodies/objects which are non-removable; pregnancy (or its possibility); previous brain and/or heart surgery; and fear of tight spaces.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- University of Pittsburghcollaborator
- National Aeronautics and Space Administration (NASA)collaborator
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Dinges, PhD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2018
First Posted
December 24, 2018
Study Start
February 22, 2019
Primary Completion
December 10, 2024
Study Completion
February 28, 2025
Last Updated
April 6, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share